1720 — Standard Chem & Pharm Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapSuper Stock

Annual cashflow statement for Standard Chem & Pharm Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	586	773	1,014	1,400	1,438
Depreciation
Amortisation
Non-Cash Items	-11.9	-23	-70.8	-50.1	-78.8
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-150	-61.1	-337	-421	-370
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	638	923	827	1,228	1,337
Capital Expenditures	-179	-353	-218	-1,200	-628
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-101	-357	1,037	119	143
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-280	-710	819	-1,081	-486
Financing Cash Flow Items	227	-60.6	-51.6	-120	-156
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities	-138	-644	-118	-465	-1,076
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	218	-436	1,528	-305	-223